Stryker is positioned for success in robot sales and market gains, thanks to its robust portfolio and in-demand robotic surgery platform, according to an analysis by Zacks Equity Research.
Spinal Tech
The medical device mergers and acquisitions market has been active this past year.
ChoiceSpine appointed new executive leaders in an attempt to drive sales growth.
The global orthopedic devices market is forecasted to exceed $55 billion by 2025, according to a Global Market Insights report published on pharmaphorum.
Amplify Surgical launched its dualX earlier this year and it has now been implanted in 100 surgical levels.
The FDA cleared 31 orthopedic-related devices in September.
In a nearly decades-old case, the U.S. Supreme Court has declined to review its decision in a patent infringement case between Stryker and Zimmer Biomet.
Xtant Medical appointed Sean Browne president and CEO.
Cosentyx, a monoclonal antibody developed by Novartis, demonstrated positive results in treating patients with non-radiographic axial spondyloarthritis, reports PhamraLive.
Centinel Spine's prodisc L lumbar total disc replacement celebrated its 18th year of clinical usage.
